Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varicella vaccine 2nd dose evaluation in Beijing
NCT01830283Phase 4Unknown
- Sponsor
- Beijing Center for Disease Control and Prevention
- Start
- Apr 2013
- Primary completion
- Jun 2013
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of varicella virus vaccine live in varicella (VZV), sponsored by Beijing Center for Disease Control and Prevention. Status: unknown.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT01830283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830283.